Section 13
Chapter 12,983

In vitro effects of dexamethasone on mouse ovarian function and pre-implantation embryo development

Van Merris, V.ér.; Van Wemmel, K.; Cortvrindt, R.

Reproductive Toxicology 23(1): 32-41


ISSN/ISBN: 0890-6238
PMID: 17000079
DOI: 10.1016/j.reprotox.2006.08.008
Accession: 012982831

The effect of dexamethasone (5-80 microg/ml) on ovarian function and embryo development was studied in mice. The follicle bio-assay revealed no effects of DEX up to 40 microg/ml on folliculogenesis and oogenesis, whereas 80 microg/ml hampered follicle differentiation and oocyte maturation. Androgen, estrogen and progestin secretion patterns were strongly impaired at all doses levels. However, the ovulation-induced progesterone increase indicating that the steroid pathway was activated in presence of DEX. Applying the oil-free mouse embryo assay no alteration of DEX on the first cleavage stages were observed whereas blastocyst rate decreased from 20 microg/ml DEX onwards, and hatching capacity was already impaired in presence of 10 microg/ml DEX. In conclusion, steroidogenesis was affected from 5 microg/ml onwards and the minimum effective inhibitory dose was set at 10 microg/ml for early embryo development. Based on these in vitro findings, physiological or therapeutic levels of glucocorticosteroids are unlikely to affect female fertility.

PDF emailed within 0-6 h: $19.90